The model-based approach to clinical studies in particle radiotherapy - A new concept in evidence based radiation oncology?

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 265-266

  Grau, Cai ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; CANCER RADIOTHERAPY; CLINICAL DECISION MAKING; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; MEGAVOLTAGE RADIOTHERAPY; ONCOLOGY; PATIENT CARE; PHOTON THERAPY; PRIORITY JOURNAL; PROCESS MODEL; PROTON THERAPY; RADIOBIOLOGY; TREATMENT PLANNING;

HUMANS; PATIENT SELECTION; PROTONS;

EID: 84881475991     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.06.031     Document Type: Editorial

References (25)

1. Langendijk JA, Lambin P, De Ruysscher D, Widder J, Bos M, Verheij M. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol 2013;107:267-73.
2. R.B. Jimenez, C. Goma, and J. Nyamwanda Intensity modulated proton therapy for postmastectomy radiation of bilateral implant reconstructed breasts: a treatment planning study Radiother Oncol 107 2013 213 217
3. F. Fellin, R. Azzeroni, and A. Maggio Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treatment planning comparison Radiother Oncol 107 2013 207 212
4. J.A. Efstathiou, J.J. Paly, and H.M. Lu Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk Radiother Oncol 103 2012 12 17
5. S. Sugahara, T. Kamada, and R. Imai Carbon ion radiotherapy for localized primary sarcoma of the extremities: Results of a phase I/II trial Radiother Oncol 105 2012 226 231
6. C.B. Simone 2nd, D. Ly, and T.D. Dan Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer Radiother Oncol 101 2011 376 382
7. S. Kim, B.J. Min, and M. Yoon Secondary radiation doses of intensity-modulated radiotherapy and proton beam therapy in patients with lung and liver cancer Radiother Oncol 98 2011 335 339
8. M. Stuschke, A. Kaiser, C. Pöttgen, W. Lübcke, and J. Farr Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans Radiother Oncol 104 2012 45 51
9. H.A. Wolff, D.M. Wagner, and L.-C. Conradi Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications Radiother Oncol 102 2012 30 37
10. M. Schwarz, A. Pierelli, and C. Fiorino Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison Radiother Oncol 98 2011 74 80
11. R.C. Miller, M. Lodge, M.H. Murad, and B. Jones Controversies in clinical trials in proton radiotherapy: the present and the future Semin Radiat Oncol 23 2013 127 133
12. D. De Ruysscher, M.M. Lodge, and B. Jones Charged particles in radiotherapy: a 5-year update of a systematic review Radiother Oncol 103 2012 5 7
13. M. Lodge, M. Pijls-Johannesma, L. Stirk, A.J. Munro, D. De Ruysscher, and T. Jefferson A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer Radiother Oncol 83 2007 110 122
14. D.R. Olsen, O.S. Bruland, G. Frykholm, and I.N. Norderhaug Proton therapy - a systematic review of clinical effectiveness Radiother Oncol 83 2007 123 132
15. A.M. Allen, T. Pawlicki, and L. Dong An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee Radiother Oncol 103 2012 8 11
16. M. Goitein Trials and tribulations in charged particle radiotherapy Radiother Oncol 95 2010 23 31
17. D. Zips, and M. Baumann Place of proton radiotherapy in future radiotherapy practice Semin Radiat Oncol 23 2013 149 153
18. M. Brada, M. De Pijls-Johannesma, and D. Ruysscher Proton therapy in clinical practice: current clinical evidence J Clin Oncol 25 2007 965 970
19. H. Suit, H. Kooy, and A. Trofimov Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? Radiother Oncol 86 2008 148 153
20. M. Goitein, and J.D. Cox Should randomized clinical trials be required for proton radiotherapy? J Clin Oncol 26 2008 175 176
21. S.M. Bentzen Randomized controlled trials in health technology assessment: overkill or overdue? Radiother Oncol 86 2008 142 147
22. M. Goitein, and M. Jermann The relative costs of proton and X-ray radiation therapy Clin Oncol (R Coll Radiol) 15 2003 S37 S50
23. M. Pijls-Johannesma, P. Pommier, and Y. Lievens Cost-effectiveness of particle therapy: current evidence and future needs Radiother Oncol 89 2008 127 134
24. Y. Van den Lievens, and W. Bogaert Proton beam therapy: too expensive to become true? Radiother Oncol 75 2005 131 133
25. J. Van Loon, J. Grutters, and F. Macbeth Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it? Lancet Oncol 13 2012 e169 e177